Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.82K Buy
131
+88
+205% +$5.86K ﹤0.01% 475
2026
Q1
$2.7K Buy
43
+27
+169% +$1.88K ﹤0.01% 821
2025
Q4
$1.06K Sell
16
-150
-90% -$9.7K ﹤0.01% 901
2025
Q3
$11.2K Sell
166
-116
-41% -$9.18K ﹤0.01% 442
2025
Q2
$24.6K Sell
282
-15
-5% -$1.18K 0.01% 329
2025
Q1
$20.3K Sell
297
-16
-5% -$1.31K 0.01% 345
2024
Q4
$24.3K Sell
313
-221
-41% -$16.4K 0.01% 334
2024
Q3
$35.8K Buy
534
+296
+124% +$24.3K 0.01% 305
2024
Q2
$16.6K Buy
238
+171
+255% +$21.6K 0.01% 361
2024
Q1
$8.31K Hold
67
﹤0.01% 448
2023
Q4
$8.31K Buy
+67
New +$6.84K ﹤0.01% 448

Other funds holding DXCM

Sachetta's DXCM Position: Q2 2026 in Review

Sachetta increased its DexCom (DXCM) stake by 205% in Q2 2026, buying an estimated $5.86K and bringing the position to 131 shares worth $8.82K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Sachetta first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $35.8K in Q3 2024. 170 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sachetta held 131 shares of DexCom worth $8.82K as of Q2 2026.
  • Sachetta bought 88 DexCom shares in Q2 2026, an estimated $5.86K.
  • DexCom made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #475 holding.
  • Sachetta first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's DexCom position peaked at $35.8K in Q3 2024.
  • 170 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.